Predicted Price is the pryogiTM prediction of where the price is going in next 3-4 quarters. There may be a revision of the predicted price every 3 months from the date of publication of the first predicted price of the stock. Price on Report Date is the price of the stock on the day prediction was published by pryogiTM. Current price shows the current price of the stock.
Margin of error shows range the price will end up in dollars either above or below the predicted price. Margin of error percentage shows the price will end up in percentage either above or below the predicted price.
Expected Returns from report date shows the returns (positive or negative) from published prediction date if you bought the stock on report date. Expected Returns from today shows the returns from today if you buy the stock today. A positive expected returns indicates a profit you will make, a negative expected return indicates a loss you will make if you buy the stock. There are different strategies to apply in the stock market for profit and loss, pryogiTM will publish such strategies in the future to help you.
PryogiTM meter shows you predicted price, price on the date this prediction was published(report date) and price of the stock today on a price scale. This indicates if the stock price is moving towards or away from the predicted price
PryogiTM performance chart shows actual movement of stock price from prediction published date(report date) and if the price is moving towards or away from predicted price
Wedbush initiated coverage on CG Oncology (NASDAQ:CGON) with an "Outperform" rating and a $70 price target, suggesting a significant upside. Other analysts have also issued ratings, contributing to a consensus of "Moderate Buy" with an average target price of $60.58. Recent insider selling and institutional investor activity reflect ongoing movements in the company's stock.
Kellanova is launching new co-branded products and innovative items in 2025 despite its impending acquisition by Mars, Inc. The company has partnered with Golden West Food Group for Eggo and Rice Krispies Treats ice cream lines and with Wendy's for a Baconator Cheez-It cracker. Kellanova is also expanding into the protein trend with new RXBAR high-protein bars made with pea protein and agave nectar.
ANI Pharmaceuticals Director Renee Tannenbaum sold 1,800 shares of the company's stock for $146,070, reducing her stake by 6.68%. This transaction follows strong quarterly earnings where ANI Pharmaceuticals exceeded analyst estimates and provided positive FY2025 guidance. Analysts maintain a "Buy" rating on the stock with an average target price of $99.38.
Oklahoma's new legislation restricting foreign ownership of farmland has exempted Smithfield Foods, a Chinese-owned company, despite concerns about Chinese influence over U.S. agriculture. This exemption is due to Smithfield's earlier agreement with the Committee on Foreign Investment in the U.S. (CFIUS). While other states like Arkansas have forced divestment, Oklahoma lawmakers have included specific carve-outs that shield Smithfield, highlighting a selective enforcement of anti-China legislation.
Lombard Odier Asset Management USA Corp recently acquired a new stake in Cencora, Inc. (NYSE:COR) by purchasing 10,534 shares worth approximately $3.16 million during the second quarter. This investment highlights institutional interest in Cencora, with hedge funds and institutional investors collectively owning a significant portion of the company's stock. The article also details recent insider selling activities, Cencora's financial performance, dividend increase, and analyst ratings.
Norges Bank recently acquired 688,357 shares of American Healthcare REIT (AHR) for approximately $25.29 million, representing about 0.43% ownership. This purchase comes amidst several analyst upgrades and a consensus "Buy" rating with a target price of $51.64. Despite a quarterly dividend, the company's high payout ratio of 714.29% raises concerns about its sustainability.
Gabelli Funds LLC increased its stake in Nexstar Media Group, Inc. (NASDAQ:NXST) by 69.8% during the second quarter, acquiring an additional 35,596 shares. The fund now owns 86,596 shares of the company, valued at approximately $14,977,000. Other institutional investors have also adjusted their holdings in Nexstar Media Group, which recently reported Q3 earnings and declared a quarterly dividend.
Gabelli Funds LLC decreased its stake in Cencora, Inc. (NYSE:COR) by 6.6% in the second quarter, selling 3,355 shares and now owning 47,770 shares valued at approximately $14.32 million. Concurrently, other institutional investors adjusted their positions, and company insiders, including CEO Robert P. Mauch and Chairman Steven H. Collis, sold significant shares. Despite these reductions, analysts maintain a "Moderate Buy" consensus rating for Cencora with an average target price of $373.50, and the company recently increased its quarterly dividend.
A Florida judge declared a mistrial in a lawsuit brought by sixteen Florida hospitals against Walmart, CVS, and Walgreens, which accused the pharmacy chains of contributing to the opioid crisis in the state. The jurors deliberated for 14 days but could not reach a unanimous verdict in the case alleging the companies flooded the state with opioids and violated anti-racketeering laws. The hospitals claimed that the surge in opioid use led to injuries they had to treat, often without reimbursement, racking up significant unpaid bills.
Walleye Capital LLC significantly increased its stake in Cencora, Inc. (NYSE:COR) by 258.7% in Q2, bringing its total holdings to 8,903 shares valued at approximately $2.67 million. Cencora recently exceeded Q3 earnings expectations with an EPS of $3.84 and revenue of $83.73 billion, while also raising its dividend and providing positive FY2026 EPS guidance. Despite strong institutional investment, insiders have recently sold over $14 million in shares, including transactions by the CEO and Chairman.
Cerity Partners LLC reduced its stake in Thermo Fisher Scientific Inc. by 0.9%, selling 2,142 shares and retaining 224,635 shares valued at approximately $91.08 million. This comes amidst significant insider selling, with COO Michel Lagarde selling 32,000 shares and other insiders selling a total of 149,271 shares in the last three months. Thermo Fisher Scientific has also announced a $5.0 billion stock repurchase program, declared a quarterly dividend of $0.43, and reported strong Q3 earnings exceeding estimates, along with positive FY2025 guidance.
Federated Hermes Inc. significantly increased its stake in Cencora, Inc. (NYSE:COR) by 24.1% in the second quarter, acquiring an additional 133,907 shares to own a total of 688,656 shares valued at approximately $206.5 million. Cencora recently reported better-than-expected quarterly earnings of $3.84 EPS and revenue of $83.73 billion, while also raising its quarterly dividend to $0.60 per share. Despite some insider selling, institutional investors own a substantial 97.52% of the company, and analysts generally maintain a "Moderate Buy" rating with an average price target of $371.09.
Federated Hermes Inc. increased its stake in Cardinal Health, Inc. by 11.2% in the second quarter, acquiring an additional 88,345 shares to own a total of 878,986 shares valued at approximately $147.67 million. Cardinal Health (NYSE:CAH) exceeded quarterly expectations with EPS of $2.55 and revenue of $64.01 billion, and has set FY2026 EPS guidance between $9.65 and $9.85. The company declared a quarterly dividend of $0.5107 per share, resulting in an annualized yield of about 1.0%, and holds a consensus analyst rating of "Moderate Buy" with a target price of $206.57.
Schroder Investment Management Group significantly increased its stake in Intellia Therapeutics (NASDAQ:NTLA) by 1,593.4% in the second quarter, now holding 406,425 shares valued at $3.81 million. Other institutional investors also adjusted their positions, and despite a mixed Wall Street sentiment with a consensus "Hold" rating and an average price target of $18.43, the company beat its Q3 EPS estimates. Intellia Therapeutics, (NTLA) currently trades at $9.61 with a market cap of $1.11 billion, though it remains unprofitable.
Amundi significantly increased its stake in Cencora, Inc. (NYSE:COR) by 17.0%, now holding 1,720,278 shares valued at $500.89 million. Despite this institutional accumulation, company insiders have been net sellers, offloading shares worth approximately $14.1 million. Cencora itself reported strong financials, slightly exceeding quarterly EPS and revenue expectations and raising its quarterly dividend.
Marshall Wace LLP increased its stake in Cencora, Inc. (NYSE:COR) by 24.7% in Q2, bringing its total holdings to $96.66 million. Despite insider selling by Chairman Steven Collis and CEO Robert Mauch, analyst sentiment remains generally positive with a "Moderate Buy" consensus and an average price target of $371.09. The company also recently announced an increased quarterly dividend of $0.60 per share.
The global pharmacy market is projected to reach $3.4 trillion by 2035, growing at a 7.6% CAGR, driven by expanding healthcare systems, increased chronic disease prevalence, and digital health advancements. North America is expected to dominate, while Asia Pacific will be the fastest-evolving region. Key trends include the acceleration of digital pharmacy, the rise of specialty pharmacies, and the expansion of pharmacist-led clinical services.
)
Trupanion offers comprehensive pet insurance for cats and dogs, featuring unlimited payouts and direct vet payments, but comes with high premiums and excludes pre-existing conditions, routine care, and exam fees. While it covers hereditary and congenital issues, policies do not include wellness plans. Customer reviews are mixed, with praise for direct payments and coverage for serious illnesses, but complaints about cost and claims denials.
Hundreds of thousands of cases of cheese products sold at major retailers like Walmart, Target, and Aldi have been recalled due to potential metal fragment contamination. Ohio-based Great Lakes Cheese Co. Inc. initiated the recall covering seven different shredded cheese products across 31 states. The FDA has classified this as a "class II" recall, indicating that use or exposure to the contaminated product may cause temporary or medically reversible adverse health consequences.
UBS has maintained its Buy rating and $96.00 price target for CVS Health ahead of the company's upcoming investor day. Analysts anticipate significant upside for CVS, with an average price target implying 20% upside and high-single-digit EPS growth in the long-range plan, driven by healthcare benefits margin recovery. Key focus areas for the investor day include healthcare benefits margin recovery, mitigating Caremark recontracting risk, and stabilizing pharmacy and consumer wellness earnings.
Arrowstreet Capital Limited Partnership significantly increased its stake in CVS Health Corporation by 153% in Q2, acquiring over 3.1 million shares valued at approximately $214.24 million. This move comes as CVS reported strong quarterly earnings, beating analyst estimates with $1.60 EPS and $102.87 billion in revenue, and issued optimistic FY2025 guidance. The company maintains a "Moderate Buy" consensus rating from analysts, alongside a consistent dividend payout and growing institutional investor interest.
Small, independent hardware stores continue to struggle against big-box retailers like Home Depot and Lowe's. This article highlights the closure of several long-standing hardware businesses, including the 80-year-old Howells Hardware Store, often due to competition, rising prices, or owner health issues. Despite these closures, related businesses like Howells Glass, which was previously sold, continue to operate.
New York State Common Retirement Fund reduced its stake in Regeneron Pharmaceuticals ($REGN) by 1.9%, selling 2,471 shares and retaining 128,069 shares valued at $67.24 million. Additionally, company insiders, including VP Jason Pitofsky and Director Christine A. Poon, sold significant amounts of stock. Regeneron reported a quarterly EPS beat and higher-than-expected revenue, declared a dividend of $0.88, and holds a "Moderate Buy" analyst consensus with an average price target of $757.91.
Korea Investment CORP reduced its stake in AMETEK, Inc. by 7.8% in Q2, bringing its total holdings to 179,009 shares valued at approximately $32.4 million. This article also details other institutional investor activity, analyst ratings, and significant insider sales by CEO David A. Zapico and Ronald J. Oscher, alongside AMETEK's strong quarterly earnings beat and dividend declaration.
This article from The Motley Fool discusses Realty Income (O) as a real estate investment trust (REIT) that leases to recession-resistant retailers, highlighting its monthly dividends and appealing investment status as interest rates decline. It also offers advice from "Ask The Fool" on stock price movements and giving stock as gifts, and "The Fool's School" on Philip A. Fisher's investing principles for evaluating companies and diversification. The "My Dumbest Investment" section shares a regretful Netflix sale and a successful Apple investment.
Ulta Beauty Inc. (ULTA) stock experienced a decline on Tuesday, underperforming both its industry competitors and the broader market indices like the S&P 500 and the Dow Jones Industrial Average. The stock closed down 1.48% at $428.16, marking its second consecutive day of losses and contributing to a general trend of underperformance against its peers.
Rockefeller Capital Management L.P. decreased its holdings in Alphabet Inc. (NASDAQ:GOOGL) by 21.4% in the second quarter, selling 842,228 shares and reducing its stake to 3,087,222 shares valued at $545.24 million. Other institutional investors also adjusted their positions, and company insiders sold a significant number of shares recently. Analyst ratings for Alphabet remain largely positive with a "Moderate Buy" consensus and an average price target of $307.84.
This article provides a comprehensive list of store hours for Thanksgiving 2025, detailing which major retailers will be open and which will be closed. It highlights that most large retailers, including Walmart and Target, will be closed, while some grocery stores and specific national chains like CVS and Bass Pro Shops will operate with reduced hours. The article also notes state laws in Maine, Massachusetts, and Rhode Island that mandate closures.
This article provides a comprehensive list of stores, businesses, and city departments in El Paso, Texas, that will be open or closed on Thanksgiving Day 2025. It details the operating hours for major retailers like Walmart, Walgreens, Whole Foods, Target, Albertsons, Costco, Sam's Club, Dick's Sporting Goods, Macy's, Nordstrom, Home Depot, Lowe's, and Best Buy, as well as information on U.S. Post Office services, trash collection, and closures for various El Paso county and educational institutions.
Verity & Verity LLC reduced its stake in Gilead Sciences, Inc. by 13.4%, selling 43,792 shares, though GILD remains its sixth-largest position valued at $31.46 million. This comes as company insiders have also been selling shares, totaling $15.15 million in the last 90 days. Gilead recently exceeded quarterly earnings and revenue estimates and announced a quarterly dividend of $0.79 per share.
Rhumbline Advisers reduced its stake in Kellanova by 8.3% during the second quarter, now owning 637,059 shares valued at approximately $50.7 million. Despite this, other major institutional investors like Vanguard Group Inc. increased their holdings, and institutional investors collectively own 83.87% of the stock. Kellanova also reported strong quarterly earnings, beating EPS estimates, and declared a quarterly dividend.
Elo Mutual Pension Insurance Co increased its stake in CVS Health Corporation by 3.1% in Q2, boosting its holdings to 154,476 shares worth approximately $10.656 million. Other institutional investors also adjusted their positions in CVS, which maintains a "Moderate Buy" rating with a consensus target price of $89.41, following strong Q3 earnings and a consistent dividend.
Cencora, Inc. has released its annual Form 10-K report, detailing a robust financial performance for the fiscal year, including significant revenue and profitability growth. The report highlights strategic acquisitions, such as RCA, and an increase in diluted EPS. The company also outlines future plans for business expansion, risk management, and addresses challenges like customer contracts, international operations, and regulatory changes in the pharmaceutical supply chain.
Chambersburg has received a permit application to convert a former Rite Aid store at 415 E Queen Street into a Dollar General. This development follows Rite Aid's nationwide store closures, including its Chambersburg location, and aligns with Dollar General's ongoing expansion in the tri-state area. Dollar General already operates six stores in the Chambersburg area alone.
The Saudi Arabia Pharmacy Retail Market, valued at USD 7.34 Billion in 2024, is projected to reach USD 12.67 Billion by 2030, growing at a CAGR of 9.53%. This growth is driven by increasing demand for healthcare services, a rising and aging population, prevalent chronic diseases like diabetes and cardiovascular conditions, and government initiatives such as Vision 2030. Key market players include Nahdi Medical Company, Tadawi Medical Center, CVS Health, and Walgreens Boots Alliance, Inc.
Swiss National Bank increased its stake in Ross Stores, Inc. by 7.0% in Q2, acquiring an additional 65,000 shares to hold 995,500 shares valued at approximately $127 million. This move comes as Ross Stores exceeded quarterly expectations with EPS of $1.58 and $5.60 billion in revenue, and issued positive FY2025 guidance. Analysts maintain a "Moderate Buy" rating with an average target price of $174.07, and institutional investors collectively own 86.86% of the company's stock.
Private Management Group Inc. acquired a new stake of 1,752 shares in Micron Technology, Inc. (NASDAQ:MU) during the second quarter, valued at approximately $216,000. This article details additional institutional investor activity, analyst ratings with updated price targets, and recent insider stock sales for Micron Technology. It also provides an overview of the company's financial performance, dividend announcement, and stock performance metrics.
The Saudi Arabia Pharmacy Retail Market is projected to grow from USD 7.34 Billion in 2024 to USD 12.67 Billion by 2030, with a CAGR of 9.53%. This growth is driven by increasing healthcare demand due to a growing and aging population, rising chronic diseases like diabetes and cardiovascular conditions, and government initiatives like Vision 2030. Key market trends include the expansion of online pharmacies, while regulatory complexities pose a significant challenge.
Prudential Financial Inc. reduced its stake in International Business Machines Corporation (IBM) by 3.5% in the second quarter, selling 23,704 shares. The fund now owns 654,739 shares of IBM, valued at $193,004,000. Other institutional investors have also adjusted their positions in IBM, while analysts have issued a range of ratings and price targets for the stock.
BlackRock CEO Larry Fink has expressed concerns that New York City is losing its competitive edge to other states, citing high housing costs, rising crime, and educational anxieties among his employees. He questioned the city's resolve to address these issues, noting a decline in fundamental services and a shift in business operations and residents seeking more affordable and stable environments elsewhere. Despite past resilience, Fink's remarks suggest a changing landscape where New York must actively fight to maintain its allure against more attractive alternatives.
Jim Cramer identified three "very safe" high-dividend stocks—Enbridge, Pfizer, and Realty Income—after a volatile week on Wall Street. He explained that these companies, unlike many others with high yields, are well-positioned to maintain their dividends and offer solid returns despite market fluctuations. Cramer detailed the specific reasons each stock (Enbridge's predictable business, Pfizer's cash flow, and Realty Income's stable occupancy) makes it a lower-risk investment.
Vanguard Group Inc. increased its stake in CVS Health Corporation by 1.7% in the second quarter, bringing its total ownership to 9.49% of the company's shares, valued at approximately $8.305 billion. This increase follows strong Q3 earnings and revenue beats by CVS Health, alongside positive "Moderate Buy" ratings from Wall Street analysts and a consistent dividend payout. Other institutional investors also adjusted their positions, indicating broader interest in the pharmacy operator.
JPMorgan Chase Financial Company LLC has issued $500,000 in Auto Callable Contingent Interest Notes due November 19, 2029, which are fully and unconditionally guaranteed by JPMorgan Chase & Co. These structured investments are linked to the performance of the Consumer Discretionary Select Sector SPDR® Fund, the Energy Select Sector SPDR® Fund, and the Russell 2000® Index. The notes carry risks including potential loss of principal, no guaranteed interest payments, and credit risks of both JPMorgan Financial and JPMorgan Chase & Co.
Rockefeller Capital Management L.P. reduced its stake in Devon Energy Corporation by 8.2% during the second quarter, selling 38,803 shares and now holding 432,746 shares valued at $13.77 million. Despite this, several other large institutional investors increased their holdings, and institutional investors and hedge funds collectively own almost 70% of the stock. Analysts have a "Moderate Buy" rating with an average target price of $43.79 for Devon Energy, which recently beat EPS estimates and announced a quarterly dividend.
A Dollar Tree discount retailer is opening in the former Rite Aid location on 6912 New Falls Road in Levittown, which has been vacant since Rite Aid's closures earlier this summer. The property is valued at approximately $3.1 million and is owned by Randy Cusuman, though Dollar Tree Stores, Inc. is listed as the mailing address. It's currently unknown if a nearby Dollar Tree location will remain open once this new store is fully operational.
The Ontario Teachers Pension Plan Board purchased 4,119 shares of CVS Health Corporation, initiating a new position valued at approximately $284,000 in Q2. This comes as CVS reported strong earnings, beating expectations, and received multiple analyst price target increases, resulting in a "Moderate Buy" consensus. The article also details other institutional investor activity, stock performance metrics, dividend information, and recent insider trading.
Mount Lucas Management LP acquired a new stake of 10,607 shares in CVS Health Corporation, valued at approximately $732,000, bringing institutional ownership to 80.66%. The article also details insider trading activity, with Director Anne A. Finucane selling 7,500 shares, and outlines recent analyst ratings, stock performance, and the company's latest earnings report and dividend announcement.
Itau Unibanco Holding S.A. acquired 27,500 shares of Kenvue Inc. (KVUE) in Q2, valued at approximately $576,000, contributing to institutional investors owning 97.64% of the company. Kenvue reported Q2 EPS of $0.28, beating estimates, but revenue saw a 3.5% year-over-year decline, and its FY2025 EPS guidance is below analyst consensus. The company declared a quarterly dividend with a high payout ratio, raising questions about sustainability.
CONMED Corporation (NYSE:CNMD) has received an average "Hold" recommendation from brokerages, with an average 12-month price target of $54.00. Several analysts recently trimmed price targets and ratings, while the company modestly beat quarterly estimates and set optimistic FY2025 guidance. Insider activity shows a director selling shares, and institutional investors have also adjusted their holdings.
A supermarket news article focuses on a "produce scandal" at Kroger, where shoppers have allegedly been paying top dollar for produce due to a pricing kickback scheme involving a former buyer. The article is part of a "5 things top news" series and highlights the legal development of a former buyer pleading guilty.